Grace Therapeutics, Inc. (GRCE)
Stock-Based Compensation
$395.00K
TTM · Period ending: · USD
GRCE Stock-Based Compensation
Latest reported$395.00Kperiod ending
Latest reported$395.00Kperiod ending
GRCE Stock-Based Comp ($0.00 → $395.00K)
Annual stock-based compensation
High-resolution chart · PNG
GRCE stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 798,000 | |
| 730,000 | |
| 913,000 | |
| 1,811,000 | |
| 1,337,000 | |
| 1,474,833 | |
| 2,760,711 | |
| 777,000 | |
| 719,368 | |
| 0 | |
| 228,025 | |
| 1,241,238 | |
| 3,093,235 | |
| 1,872,739 | |
| 1,328,234 | |
| 185,147 | |
| 0 | |
| 0 |